3292 results

A short history of the Euro4C Group

16 Jan 2019

Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

PCR London Valves 2021 – Welcome message

Read words from #PCRLV Course Directors for the on-site and online participants

PCR Webinars on bifurcation lesion: words from Goran Stankovic

15 Jul 2019

Read the article with input from Goran Stankovic on this free series of modules that have been carefully prepared by a team of experts and are available both live and on replay

Bentley acquired the GoBack catheter

13 Sep 2022

World Heart Day 2022: Sub-Saharan Africa - the underserved continent when it comes to cardiovascular disease care

29 Sep 2022

The humble and noble ambition of SHARE (Sustain Health development in Africa through Responsible Education) is to identify a favorable environment in sub-Saharan countries where catheter labs can be established.

First Patient Enrolled in SELUTION SLR IDE BTK Study

08 Jun 2022

Artificially synthesized optical coherence tomography images based on intravascular ultrasound-virtual histology examination of diseased coronary artery

05 May 2021

Intravascular imaging is a cornerstone of invasive management of coronary disease, requiring specialized training to interpret either IVUS or OCT. AI can facilitate interpretation by non-specialists in real time.

World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!

29 Sep 2023

Global burden of Cardiovascular Disease

Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...

Author

Vijay Kunadian

How to snare a TAVI when crossing is too complex

30 Jan 2025

Crossing the aortic valve can pose significant challenges, particularly in cases involving a horizontal aorta, bulky asymmetric calcifications, or prior prosthesis implantation in valve-in-valve procedures. While some TAVI devices feature deflectable delivery systems to enhance coaxiality, current self-expanding valves lack this capability. When standard techniques like...

Author

Francesco Tartaglia

Author

Damiano Regazzoli

Author

Ottavia Cozzi

Author

Marta Bande

Author

Antonio Mangieri

Performing BASILICA: a step-by-step guide to prevent coronary obstruction during TAVI

05 Aug 2025

Author

Ahmed Abdelhafez

Author

Mohamed Abdel-Wahab

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase

Fractional flow reserve-guided complete or culprit-only PCI in patients with ST-elevation myocardial Infarction - FULL REVASC

08 Apr 2024

Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.

The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...

Author

Nicola Ryan

Sensome announces data from two new studies showing clot-sensing guidewire successfully identifies fresh clot to support decision-making in peripheral artery disease treatment

13 Dec 2024

Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

18 May 2022

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Author

Nicola Ryan

SWEDEHEART: Improving the quality of cardiology care in Sweden and beyond!

22 May 2025

Lars Wallentin and Stefan James received the Andreas Grüntzig Ethica Award during EuroPCR 2025, on behalf of a wider team of cardiovascular registry experts who have contributed in an extraordinary way to the PCR mission. 

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

Simultaneous aortography and left ventriculography for transcatheter valve-in-valve implantation in patients with a stentless bioprosthetic aortic valve

16 Dec 2022

Thanks to this image in cardiology, watch how an 82-year-old female patient underwent transcatheter ViV implantation for symptomatic severe SVD of the stentless pericardial bioprosthesis that had been implanted 4 years ago.

Protein and exercise to reverse frailty in older men and women undergoing transcatheter aortic valve replacement: The PERFORM-TAVR Trial

08 Apr 2024

Panos Xaplanteris provides his take on the results of PERFORM-TAVR presented by Jonathan Afilalo at ACC.24 in Atlanta.

Author

Panagiotis Xaplanteris